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UniveFemale sex is associated with comparable 5-year
outcomes after contemporary endovascular aneurysm
repair despite more challenging anatomyThomas F. X. O’Donnell, MD,a,b Hence J. Verhagen, MD, PhD,c Giovanni Pratesi, MD,d Carlo Pratesi, MD,e
Joep A. W. Teijink, MD,f,g Frank E. G. Vermassen, MD, PhD,h Patrice Mwipatayi, MD,i Thomas L. Forbes, MD,j
and Marc L. Schermerhorn, MD, FACS,a Boston, Mass; Rotterdam, Eindhoven, and Maastricht, The Netherlands; Rome
and Florence, Italy; Ghent, Belgium; Perth, Western Australia, Australia; and Toronto, Ontario, CanadaABSTRACT
Background: Women with abdominal aortic aneurysms less often meet anatomic criteria for endovascular repair and
experience worse perioperative and long-term survival.
Methods: We compared long-term survival, aneurysm-related mortality, and rates of endoleaks and reinterventions
between male and female patients in the Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE)
using 2:1 propensity score matching.
Results: There were 1130 male patients and 133 female patients, yielding 399 patients after matching (266 male patients,
133 female patients). Female patients were older, with smaller aneurysms, smaller iliac arteries, and shorter, more
angulated necks, and they were more often treated outside the device instructions for use (all P < .001). Through 5 years,
female patients experienced overall mortality comparable to that of well-matched male patients (34% vs 38%, respec-
tively; hazard ratio, 0.89 [0.61-1.29]; P ¼ .54) and lower aneurysm-related mortality (0% vs 3%; P ¼ .047). Female patients
experienced higher rates of any postoperative type IA endoleak through 5 years (10% vs 1%; P < .001) but comparable
rates of secondary endovascular procedures (14% vs 16%; P ¼ .40). Female sex was independently associated with
significantly higher risk of long-term type IA endoleaks (hazard ratio, 4.8 [1.2-20.8]; P ¼ .04), even after accounting for
anatomic factors. No female patient experienced aneurysm rupture during follow-up, and only one female patient un-
derwent conversion to open repair.
Conclusions: Despite more challenging anatomy, female patients in the ENGAGE registry had long-term outcomes
comparable to those of male patients. However, female patients experienced higher rates of type IA endoleaks. Although
standard endovascular aneurysm repair remains a viable solution for most women, whether high-risk patients may be
better served with open surgery, custom-made devices, EndoAnchors (Aptus Endosystems, Sunnyvale, Calif), or chimneys
is worthy of further study. (J Vasc Surg 2020;71:1179-89.)
Keywords: Abdominal aortic aneurysm; Sex; Endovascular aneurysm repair; Gender; EVARAbdominal aortic aneurysms (AAAs) disproportionately women, with an AAA between 5.0 and 5.4 cm may
affect men at a 4:1 ratio, but women with AAAs suffer
worse outcomes.1-5 Aneurysms in women rupture four
times as frequently and at smaller diameters. Conse-
quently, many argue that women should undergo repair
earlier and suggest updating the current sex-neutral 5.5-
cm diameter threshold for repair.2,4,6-8 Indeed, the most
recent guidelines from the Society for Vascular Surgery
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ARTICLE HIGHLIGHTS
d Type of Research: Retrospective analysis of prospec-
tively collected data from the Endurant Stent Graft
Natural Selection Global Postmarket Registry
(ENGAGE)
d Key Findings: After endovascular aneurysm repair,
133 female patients experienced comparable 5-year
mortality to that of 166 matched male patients and
lower aneurysm-related mortality, with no ruptures.
Female patients experienced higher rates of type IA
endoleaks (10 vs 1), even after accounting for
anatomic factors, but similar reinterventions.
d Take Home Message: Female patients experience
long-term outcomes after endovascular aneurysm
repair similar to those of men, although alternative
strategies may be needed for female patients with
adverse neck anatomy.
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April 2020women eligible for repair. However, before aneurysm
repair can be expanded to this vulnerable population,
the gap in outcomes after repair needs to be bridged.
Multiple trials and a recent meta-analysis demon-
strated higher perioperative and long-term morbidity
and mortality for women compared with men after
both open and endovascular repair.4,6,14-17 Women expe-
rience higher mortality than men after endovascular
repair, but this difference is even more pronounced after
open repair. Despite operative mortality after open repair
of almost twice that of men, women are less likely to un-
dergo endovascular aneurysm repair (EVAR).16 Women
less often meet device instructions for use (IFU) and are
more likely to have unsuitable anatomy, largely because
of shorter, more angulated necks and inadequate access
vessel size. As a consequence of their smaller vessels,
women undergo adjunctive access procedures more
frequently than men and experience higher rates of
access complications.18,19 Until the sex gap in outcomes
after AAA repair narrows by expanding the eligibility for
EVAR or improving outcomes, it will remain difficult to
advocate expanding the use of AAA repair in women.
Early pivotal trial results in addition to long-term, real-
world data from the Endurant Stent Graft Natural
Selection Global Postmarket Registry (ENGAGE) demon-
strated low morbidity and mortality, and several series
documented success in treating patients with chal-
lenging anatomy even outside the IFU.20-23 In 2013,
Dubois et al24 demonstrated equivalent perioperative re-
sults between men and women in the ENGAGE registry.
We therefore studied whether this low-profile, widely
applicable stent graft would narrow the sex gap and
whether the outcomes remained durable over time in
the ENGAGE registry.
METHODS
Study design and participants. Full methodologic
details of the ENGAGE registry and rationale of data collec-
tion have been published previously, as have technical
specifications of the Endurant Stent Graft System (Med-
tronic, Santa Rosa, Calif).20-23 Briefly, ENGAGE is a pro-
spective, real-world registry of standard infrarenal EVARs,
with minimal inclusion and exclusion criteria compared
with the extensive requirements of investigational device
exemption trials. Informed consent was obtained from all
patients at the time of enrollment for authorization of
data release. To date, the registry has enrolled a total of
1263 patients at 79 centers over a wide, multinational
geographic area in 30countries spanning six continents. All
participating candidate ENGAGE registry sites were
required to seek and to obtain Institutional Review Board
approval of the protocol if applicable, and the protocol is
registered on clinicaltrials.gov (NCT01379222).
Outcomes. Our primary outcome was 5-year survival.
Secondary outcomes included procedural results (tech-
nical success, length of stay, endoleaks) and 5-year ratesof type I and type III endoleaks and secondary proced-
ures. All deaths were reviewed and adjudicated by the
Clinical Events Committee, consisting of three indepen-
dent vascular surgeons or radiologists. Follow-up
occurred at 1 month, at 12 months, and then yearly
afterward. Computed tomography angiography (CTA)
was recommended by trial protocol at 1 month and
1 year, and subsequent follow-up (CTA vs duplex ultra-
sound) studies were at the discretion of the institutions.
The imaging modality most frequently used at the 1-year
follow-up visit was CTA (48% of follow-up imaging); but
over time, ultrasound use became more frequent, and at
the 5-year follow-up only 31% were CTA compared with
52% ultrasound. All CTA images were analyzed using
three-dimensional reconstructions.
Statistical analysis. We compared baseline and
anatomic characteristics using standard statistical
methods, including Student t-test or Wilcoxon rank
sum test for continuous variables and Cochran-Mantel-
Haenszel test for categorical variables.
In our primary analysis, we used propensity scorematch-
ing to account for differences in baseline characteristics.
We generously introduced covariates into our model,
including age, hypertension, hyperlipidemia, diabetes,
cancer, alcoholism, cardiac disease (coronary artery dis-
ease, congestive heart failure, prior myocardial infarction,
coronary artery bypass grafting, percutaneous coronary
intervention), pulmonary disease, renal disease, cerebro-
vascular disease, peripheral vascular disease, familyhistory
of AAA, American Society of Anesthesiologists class, and
procedure year. To increase the generalizability of our
analysis, anatomic characteristics were not included in
our propensity score models. This allowed the previously
described anatomic differences between the sexes to
persist. We wanted to evaluate whether outcomes
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differences orwhether theadvances inendograft technol-
ogy were able to surmount these differences. Essentially
we sought to determine whether modern endografts
had narrowed the outcomes gap for all patients or just
for patients with more favorable anatomy. Therefore, for
our initial analysis, we allowed anatomic differences to
persist to better reflect the population at large and per-
formed a secondary analysis (described later) in which
we directly examined the effect of patients’ anatomy.
Each female patientwasmatchedwith twomalepatients
by propensity scores using the nearest neighbor method.
After matching, the standardized differences were
all <10% (the usual threshold) except for pulmonary dis-
ease and procedure year of 2011 (11% and 12%, respec-
tively), indicating minimal imbalance. We compared
survival estimates of all-cause mortality, aneurysm-
relatedmortality, type I and type III endoleaks, and reinter-
ventions in the matched cohort using the log-rank test,
and thehazard ratio (HR)was computedusingCox regres-
sion. Cox regression models were tested for violations of
the proportional hazards assumption using the propor-
tionality test. There was <15% missingness for all covari-
ates in the propensity score model. Missing data were
imputed using the sex-specific median for propensity
modeling. Cause of death was adjudicated by the Clinical
Events Committee, which consists of three independent
vascular surgeons or radiologists.
As a secondary analysis, we sought to determine
whether disparate outcomes between the sexes were
explained by the inherent anatomic differences or
whether female sex would still be independently associ-
ated with type IA endoleaks after adjustment for age and
anatomy. To do this, we used Cox regression modeling
with long-term type IA endoleaks as the outcome. This
model adjusted for sex, age, and anatomic factors
including aneurysm diameter, proximal neck length,
proximal neck diameter, distal neck diameter, iliac diam-
eter, and infrarenal neck angle. Two separate models
were made; the first included anatomic data as contin-
uous variables, and the second included the anatomic
factors as binary variables based on whether they
violated the manufacturer’s IFU.
Data management and statistical analysis. The data
from the patients in the ENGAGE registry are recorded
on a web-based electronic case report (Veracity Clinical
Asset Management; Merge Healthcare, Chicago, Ill). Data
are entered under the supervision of each site’s principal
investigator and are managed by the Medtronic Biosta-
tistics and Data Management Department (Santa Rosa,
Calif). It reviews 100% of data to detect missing or
inconsistent data to generate queries to the investigators
for resolution. In addition to this, Medtronic Bakken
Research Centre BV (Maastricht, The Netherlands)
randomly monitors >40% of patients’ sourcedocumentation against the data entered. It also
performed a verification of all 1263 patient informed
consents and essential study documents at each site.
Role of the funding source. The statistical analyses
were performed by an independent third party (Baim
Institute for Clinical Research, formerly Harvard Clinical
Research Institute, Boston, Mass) that had access to all
of the data, at the guidance of the authors. The authors
did not receive funding from the industry source, wrote
the manuscript, and had final responsibility for the deci-
sion to submit for publication.
RESULTS
Baseline characteristics and anatomic details. We
identified 1263 patients, 1130 male (89%) and 133 female
(11%). After matching, there were 133 female patients and
266 male patients. Baseline characteristics before and af-
ter matching are presented in Tables I and II, and
anatomic characteristics are presented in Table III. Before
matching, female patients were older, with lower rates of
documented cardiac disease, but were more American
Society of Anesthesiologists class 4 patients and more
often had a family history of aortic aneurysms (all P < .05).
Female patients had smaller aneurysms (58 6 10 mm vs
616 12mm; P¼ .01); smaller iliac arteries (136 3mmvs 146
4 mm; P < .001); and shorter, smaller, more angulated
necks (neck length <10 mm, 4.5% vs 1.9% [P ¼ .049];
infrarenal neck angle >60 degrees, 19.7% vs 9.0% [P <
.001]). Correspondingly, female patients were treated
outside the IFU twiceasoftenasmen (32%vs 16%;P< .001).
Perioperative events. Compared withmale patients, fe-
male patients experienced higher rates of type I (12.9% vs
6.6%; P < .01) and type II endoleaks (20.5% vs 13.7%; P ¼
.04) seen on any intraoperative angiogram, but there
was no difference in the rates of any endoleaks at the
end of the case (type I, 1.5% vs 1.1% [P ¼ .64]; type II,
15.9% vs 12.1% [P ¼ .20]; Table IV). The Endurant II is a
semiporous graft and can have type IV endoleaks that are
difficult to differentiate fromother leaks until the 1-month
scan. Indeed, many of the endoleaks initially thought to
be type I may in fact have been type IV as the majority
were no longer visible by case end, and only 14 patients (4
women, 10 men) had type I endoleaks at 1-month follow-
up (3% and 1%, respectively). Male and female patients
experienced comparable procedure times, adjunctive
procedures, technical success rates, estimated blood loss,
contrast material volume, fluoroscopy time, and post-
operative intensive care unit stays. However, female pa-
tients underwent hypogastric coiling less frequently (1.5%
vs 5.6%; P ¼ .04) and experienced longer lengths of post-
procedure stay (6 6 6 days vs 5 6 5 days; P < .01).
Five-year mortality, rupture, and conversion. Matched
female and male patients experienced comparable
5-year mortality rates of 34% and 38%, respectively
Table I. Baseline characteristics of the study cohort
Baseline characteristics Male patients (n ¼ 1130) Female patients (n ¼ 133) P value
Age, years, mean 6 SD 72.8 6 8.1 75.7 6 7.1 <.001
Alcoholism 3.6 (39/1098) 0.8 (1/131) .089
Cardiac disease 54.7 (618/1129) 45.1 (60/133) .035
Myocardial infarction 27.6 (297/1077) 18.2 (24/132) .021
Arrhythmia 16.2 (179/1103) 15.3 (20/131) .777
Angina 16.1 (177/1102) 12.8 (17/133) .326
Congestive heart failure 5.6 (62/1099) 6.9 (9/131) .569
Coronary artery disease 36.4 (396/1088) 21.4 (28/131) <.001
CABG or PCI 28.9 (322/1113) 12.9 (17/132) <.001
Valvular heart disease 6.2 (68/1103) 6.0 (8/133) .946
Pulmonary disease 25.4 (282/1111) 26.0 (34/131) .887
Renal insufficiency 15.5 (173/1119) 16.5 (22/133) .745
Carotid artery disease 10.8 (102/943) 11.6 (13/112) .800
Cerebrovascular/neurologic disease 12.8 (144/1129) 12.8 (17/133) .993
Transient ischemic attack 4.7 (52/1117) 6.8 (9/132) .276
Cerebrovascular accident 5.6 (63/1123) 3.0 (4/132) .213
Paraplegia 0.2 (2/1122) 0.8 (1/133) .200
Paraparesis 0.9 (10/1123) 0.0 (0/133) .275
Vascular disease 31.2 (352/1129) 29.3 (39/133) .662
Previous AAA 1.8 (20/1123) 0.0 (0/133) .121
Any thoracic aneurysm 1.8 (19/1081) 3.1 (4/127) .278
Peripheral vascular disease 19.1 (213/1113) 12.9 (17/132) .080
Thromboembolic event 3.3 (36/1106) 3.8 (5/131) .734
Bleeding 2.0 (23/1129) 0.0 (0/133) .097
Liver disease 2.4 (27/1129) 1.5 (2/133) .518
Gastrointestinal complications 19.0 (214/1129) 27.1 (36/133) .026
Family history of aneurysms 6.2 (70/1129) 12.0 (16/133) .012
Additional medical history
Cardiac disease 0.4 (5/1130) 0.0 (0/133) .442
Cerebrovascular/neurologic
disease
0.3 (3/1130) 0.0 (0/133) .552
Vascular disease 0.4 (5/1130) 0.0 (0/133) .442
Gastrointestinal complications 0.2 (2/1130) 0.8 (1/133) .198
Other 17.8 (201/1130) 27.1 (36/133) .010
ASA class .045
1 6.4 (72/1129) 3.0 (4/133)
2 41.6 (470/1129) 43.6 (58/133)
3 42.1 (475/1129) 36.8 (49/133)
SVS score .007
0 0.1 (1/1084) 0.0 (0/131) .728
1 14.3 (155/1084) 8.4 (11/131) .063
2 51.3 (556/1084) 46.6 (61/131) .307
3 34.3 (372/1084) 45.0 (59/131) .015
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiologists; CABG, coronary artery bypass grafting; PCI, percutaneous coronary
intervention; SD, standard deviation; SVS, Society for Vascular Surgery.
Categorical variables are presented as percentage (n/N).
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Table II. Baseline characteristics of the matched cohort
Measure Male patients (n ¼ 266) Female patients (n ¼ 133) P value
Age, years .881
Mean 6 SD (No.) 75.6 6 8.0 (266) 75.7 6 7.1 (133)
Median (Q1-Q3) 76.0 (70.0-81.0) 77.0 (70.0-81.0)
Range, minimum-maximum 48.0-93.0 57.0-89.0
Alcoholism 0.4 (1/261) 0.8 (1/131) .625
Cardiac disease 43.2 (115/266) 45.1 (60/133) .721
Myocardial infarction 21.9 (56/256) 18.2 (24/132) .396
Arrhythmia 14.4 (38/263) 15.3 (20/131) .829
Angina 13.8 (36/261) 12.8 (17/133) .782
Congestive heart failure 3.8 (10/261) 6.9 (9/131) .193
Coronary artery disease 27.5 (72/262) 21.4 (28/131) .193
CABG or PCI 22.5 (59/262) 12.9 (17/132) .025
Valvular heart disease 3.8 (10/262) 6.0 (8/133) .328
Pulmonary disease 21.1 (55/261) 26.0 (34/131) .278
Renal insufficiency 16.3 (43/264) 16.5 (22/133) .947
Carotid artery disease 10.4 (22/212) 11.6 (13/112) .732
Cerebrovascular/neurologic disease 11.7 (31/266) 12.8 (17/133) .744
Transient ischemic attack 4.9 (13/263) 6.8 (9/132) .446
Cerebrovascular accident 4.9 (13/265) 3.0 (4/132) .390
Paraplegia 0.0 (0/265) 0.8 (1/133) e
Paraparesis 0.4 (1/265) 0.0 (0/133) e
Vascular disease 28.6 (76/266) 29.3 (39/133) .876
Previous AAA 0.0 (0/265) 0.0 (0/133) e
Any thoracic aneurysm 1.2 (3/252) 3.1 (4/127) .199
Peripheral vascular disease 15.2 (40/263) 12.9 (17/132) .535
Thromboembolic event 3.4 (9/264) 3.8 (5/131) .837
Bleeding 1.5 (4/266) 0.0 (0/133) e
Liver disease 1.1 (3/266) 1.5 (2/133) .751
Gastrointestinal complications 20.7 (55/266) 27.1 (36/133) .154
Family history of aneurysms 12.0 (32/266) 12.0 (16/133) 1.000
Additional medical history
Cardiac disease 0.0 (0/266) 0.0 (0/133) e
Cerebrovascular/neurologic disease 0.4 (1/266) 0.0 (0/133) e
Vascular disease 0.0 (0/266) 0.0 (0/133) e
Gastrointestinal complications 0.0 (0/266) 0.8 (1/133) e
Other 19.5 (52/266) 27.1 (36/133) .090
ASA class .962
1 3.8 (10/266) 3.0 (4/133)
2 42.9 (114/266) 43.6 (58/133)
3 35.7 (95/266) 36.8 (49/133)
4 17.7 (47/266) 16.5 (22/133)
SVS score .574
0 0.0 (0/255) 0.0 (0/131)
1 11.4 (29/255) 8.4 (11/131)
2 45.1 (115/255) 46.6 (61/131)
3 43.5 (111/255) 45.0 (59/131)
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiologists; CABG, coronary artery bypass grafting; PCI, percutaneous coronary
intervention; SD, standard deviation; SVS, Society for Vascular Surgery.
Categorical variables are presented as percentage (n/N).
Journal of Vascular Surgery O’Donnell et al 1183
Volume 71, Number 4
Table III. Anatomic characteristics of the study cohort, including considerations for both United States and European
Union instructions for use (IFU)
Characteristics
Male patients
(n ¼ 1130)
Female patients
(n ¼ 133) P value
Maximum aneurysm diameter, mm 60.6 6 11.8 57.9 6 9.6 .012
Proximal neck diameter, mm 23.9 6 3.5 21.8 6 3.3 <.001
Distal neck diameter, mm 25.1 6 4.0 22.9 6 4.1 <.001
Aortic neck length, mm 27.3 6 12.4 24.5 6 11.9 .014
Proximal neck length <15 mm 11.5 (128/1117) 16.5 (22/133) .088
Right iliac artery diameter, mm 14.3 6 3.5 12.9 6 3.5 <.001
Left iliac artery diameter, mm 13.9 6 3.5 12.5 6 2.9 <.001
Infrarenal neck angle, degrees 29.4 6 23.3 38.1 6 26.2 <.001
Implantation outside of IFU 16.1 (182/1130) 32.3 (43/133) <.001
Proximal neck diameter outside of 19-32 mm 4.3 (48/1124) 17.3 (23/133) <.001
Proximal neck length <10 mm 1.9 (21/1117) 4.5 (6/133) .049
Proximal neck length $10 mm and <15 mm but infrarenal
angle >60 degrees or suprarenal angle >45 degrees
1.9 (21/1117) 3.8 (5/133) .151
Proximal neck length $15 mm but infrarenal angle >75
degrees or suprarenal angle >60 degrees
4.3 (48/1117) 8.3 (11/133) .041
Distal iliac diameter <8 mm for patients without iliac aneurysm 1.3 (15/1130) 2.3 (3/133) .393
Distal iliac diameter >25 mm for patients without iliac aneurysm 0.7 (8/1130) 0.0 (0/133) .331
Categorical variables are presented as percentage (n/N). Continuous variables are presented as mean 6 standard deviation.
1184 O’Donnell et al Journal of Vascular Surgery
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mortality was low overall but actually lower in female
patients (0% vs 3%; P ¼ .047). No female patient experi-
enced aneurysm rupture during follow-up, and only 1 of
133 female patients underwent conversion to open repair
(0.7%). Of 1130 male patients, 13 experienced aneurysm
rupture (1.2%) at a mean of 1038 days postoperatively
(range, 316-1504 days), and 18 underwent open conver-
sion (1.6%).
Five-year endoleaks and secondary procedures. In
Kaplan-Meier analysis of the matched cohort, the 5-
year rates of any endoleaks were not significantly
different between female and male patients (35% vs
27%; P ¼ .10). Female and male patients also were not
significantly different in their rates of type I or type III
endoleaks during 5-year follow-up (13% vs 8%, respec-
tively; P ¼ .13). However, female patients experienced
significantly higher rates of any long-term type IA endo-
leaks (10% vs 1%; HR, 7.17 [1.97-26.06]; P < .001; Fig 2).
Rates of long-term type III endoleaks were similar (P ¼
.41). Despite the fact that female patients experienced
higher rates of proximal endoleaks, 5-year rates of sec-
ondary endovascular procedures were similar between
female and male patients (14% vs 16%; HR, 0.77 [0.42-
1.42]; P ¼ .40; Fig 3).
In univariate analysis, female sex was associated with
significantly higher risk of type IA endoleak (HR, 7.2
[2.0-26.1]; P < .01). When age and anatomic characteris-
tics were added to themodel, female sex remained inde-
pendently associated with an almost fivefold higher riskof long-term type IA endoleaks (HR, 4.8 [1.2-20.8];
P ¼ .035). This risk was consistent regardless of whether
anatomic variables were included as continuous or bi-
nary variables. Other factors independently associated
with higher risk of type IA endoleak were a neck
length <10 mm (HR, 18.4 [3.1-109]; P ¼ .001) and a neck
angle >60 degrees (HR, 6.2 [1.7-23.1]; P < .01). There was
no interaction between female sex and neck length
(P ¼ .1) or female sex and neck angle (P ¼ .4).
Although female sex was associated with higher rates
of type IA endoleaks, this was significantly attenuated
in female patients without short or angled necks. Male
patients had a 5-year freedom from type IA endoleak
rate of 98.7% compared with 94.2% for female patients
without either a neck length <10 mm or a neck angle
>60 degrees (P ¼ .06). However, female patients with
either of these factors (24% of the sample) had a 5-year
freedom from type IA endoleak rate of 72.5% (P < .01
for comparison to other female patients as well as to
male patients).
DISCUSSION
Before the introduction of modern, low-profile stent
grafts, women less frequently underwent EVAR and
experienced inferior short- and long-term outcomes.
Our results suggest that the sex gap is narrowed in the
patients in the ENGAGE registry, but significant room
for improvement remains. Despite more challenging
anatomy and a third of female patients undergoing
EVAR outside the IFU, female patients experienced
long-term survival, aneurysm-free survival, and rates of
Table IV. Perioperative results in the full cohort
Measurement
Male patients
(n ¼ 1130)
Female patients
(n ¼ 133) P value
Procedure time, minutes 99.7 6 44.5 97.4 6 48.9 .580
Technical success 99.2 (1121/1130) 97.7 (130/133) .101
Type of anesthesia used
General 62.4 (705/1129) 60.2 (80/133) .606
Spinal 20.5 (231/1129) 27.1 (36/133) .078
Epidural 8.7 (98/1129) 3.0 (4/133) .023
Local 13.5 (152/1129) 11.3 (15/133) .482
Estimated blood loss during procedure, mL 208.3 6 224.6 208.7 6 177.3 .985
Volume of contrast material, mL 132.7 6 69.9 122.4 6 68.5 .119
Total fluoroscopy time, minutes 20.6 6 12.5 19.4 6 11.1 .276
Associated procedures performed during implant procedure
Coil embolization of hypogastric artery 5.6 (63/1130) 1.5 (2/133) .044
Right hypogastric artery 2.8 (32/1130) 1.5 (2/133)
Left hypogastric artery 2.7 (31/1130) 0.0 (0/133)
Both hypogastric arteries 0.0 (0/1130) 0.0 (0/133)
Coil embolization of IMA 0.6 (7/1130) 0.0 (0/133) .363
Other 8.8 (99/1130) 9.0 (12/133) .920
None 85.9 (971/1130) 90.2 (120/133) .172
Hospital stay, days 6.4 6 6.1 7.9 6 9.8 .017
Procedure stay, days 4.72 6 4.94 5.74 6 6.05 .005
Duration of ICU stay, hours 10.4 6 44.6 7.7 6 18.2 .312
Endoleak at case end 15.5 (174/1125) 21.2 (28/132) .089
Type I 1.1 (12/1125) 1.5 (2/132) .642
Type II 12.1 (136/1125) 15.9 (21/132) .204
Type III 0.3 (3/1125) 0.8 (1/132) .344
Type IV 1.9 (21/1125) 0.8 (1/132) .360
Undetermined 0.5 (6/1125) 2.3 (3/132) .025
Endoleak at any point of case 23.6 (265/1125) 39.4 (52/132) .003
Type I 6.6 (74/1125) 12.9 (17/132) .008
Type II 13.7 (154/1125) 20.5 (27/132) .036
Type III 1.2 (14/1125) 2.3 (3/132) .333
Type IV 2.0 (22/1125) 0.8 (1/132) .331
Undetermined 0.6 (7/1125) 3.0 (4/132) .005
ICU, Intensive care unit; IMA, inferior mesenteric artery.
Categorical variables are presented as percentage (n/N). Continuous variables are presented as mean 6 standard deviation.
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parts. However, female patients had significantly higher
rates of proximal endoleaks, even after accounting for
the anatomic differences between the sexes.
Modern endografts, with lower profile, widely applicable
IFU, and conformability, are better suited than their pre-
decessors for the complex anatomy often seen in women.
The Endurant stent graft in particular allows wider necks,
shorter neck length, smaller access vessels, and greater
angulation than other commonly implanted endografts.
Previously, Dubois et al24 published the perioperative
results of the ENGAGE registry, demonstrating excellent
and equivalent results between male and femalepatients. We confirm that these results remain durable
over time. Despite the challenging anatomy of the female
patients in our study, technical success rates were similar
to those of other modern endografts and reintervention
rates were low, especially at the proximal neck.25,26 Multi-
ple studies including this one demonstrate that women
typically have smaller, more tortuous iliac arteries,
emphasizing the need for low-profile, conformable
devices to treat aneurysms in this population.3-5,19
With significantly more hostile neck anatomy, it is not
surprising that female patients experienced significantly
higher rates of type IA endoleaks. The anatomy of the
infrarenal neck drove much of the increased risk of
Fig 1. All-cause mortality in the propensity score-matched
cohort. P ¼ .54 for comparison. SE, Standard error.
Fig 2. Five-year rates of type IA endoleaks in the pro-
pensity score-matched cohort. P ¼ .0005 for comparison.
ENGAGE, Endurant Stent Graft Natural Selection Global
Postmarket Registry; IC, investigational cohort.
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common in female patients, but female sex remained
independently associated with type IA endoleaks, even
after accounting for these anatomic factors. This is
consistent with previous studies, which consistently
demonstrate inferior outcomes in female patients, espe-
cially at the proximal neck.4,16,27,28 Reassuringly, despite a
higher rate of proximal endoleak, no female patient
experienced aneurysm rupture within 5 years, and only
one patient underwent open conversion. In comparison,
the 5 year rupture rate after EVAR in the overall Medicare
population was 3.0%.29 As the purpose of elective aneu-
rysm repair is to prevent aneurysm rupture, the results of
the Endurant II stent graft in female patients are
excellent. However, the risk of type IA endoleaks and
the divergence of the Kaplan-Meier curves over time
carry important implications for patients with difficult
necks (both men and women).
These data emphasize the challenge that patients with
hostile neck anatomy, especially female patients,
present. Female patients with short or angled necks
experienced 5-year type IA endoleak rates of 25%, which
calls into question the safety of standard EVAR in this
population. Patients with difficult neck anatomy, espe-
cially female patients, deserve careful consideration of
their suitability for advanced endovascular options as
well as open surgical repair. Fortunately, fenestrated
and branched grafts as well as chimney and snorkel
techniques present a compelling solution to the prob-
lem of hostile neck anatomy by extending the proximalseal zone, surmounting the problems presented by short
necks. In highly angulated necks, where even fenestrated
devices may be inadequate, adjuncts such as EndoAn-
chors (Aptus Endosystems, Sunnyvale, Calif) may also
help secure the proximal neck. Female patients in partic-
ular would benefit from a low-profile, conformable,
fenestrated device, given their small access vessels. This
should be a focus of device development going forward
as the success of low-profile infrarenal devices
demonstrates the critical need for similar devices in the
juxtarenal space. Fortunately, three-quarters of the
women in this study had suitable neck lengths and
neck angles, suggesting that standard EVAR remains a
viable solution for many patients.
National screening programs for AAA exist in the
United States, United Kingdom, Canada, France, and
Sweden, but none of these countries recommend
screening of women except in the presence of a family
history of AAA.30-33 However, because aneurysms in
women behave more aggressively, with higher risk of
rupture, modern studies using Markov modeling
demonstrated that screening of women would actually
be cost-effective despite lower prevalence.34,35 Women
smokers in particular stand to benefit from screening,
as the prevalence of AAA in this population probably ex-
ceeds that of nonsmoking men.36 As such, the Society for
Vascular Surgery recommends screening of women
aged 65 years or older who have smoked or have a family
history of AAA.8,37 The European Society for Vascular
Surgery, in contrast, recommends screening only of
women with a family history of AAA and states that
Fig 3. Secondary procedures in the propensity score-
matched cohort. P ¼ .40 for comparison. SE, Standard
error.
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require further investigation.”38
In addition to concerns about prevalence, the two fac-
tors limiting the expansion of screening efforts to women
and increasing the number of women undergoing elec-
tive aneurysm repair were anatomic unsuitability for
EVAR and inferior outcomes with both EVAR and open
repair.39 Previous reports from the Vascular Quality Initia-
tive and Medicare demonstrated higher perioperative
and long-term mortality in female patients.3,4,40,41 In
contrast, the results of the ENGAGE registry show that
women experienced 66% overall survival at 5 years, no
perioperative deaths, and rates of reintervention compa-
rable to those of their male counterparts. Our study adds
to the growing body of literature supporting the conten-
tion that with modern endografts and the widespread
availability of EVAR, screening paradigms for women
should be reconsidered.
This analysis must be interpreted in the context of its
design. Whereas the sample size of 133 female patients
in this analysis is high, female patients represented only
11% of the ENGAGE cohort, which is higher than in other
device registries but lower than the 17.6% in the Medicare
population.25,26,29 The substantial proportion of female
patients who underwent EVAR despite being outside
the device IFU suggests the population is not reflective
of a highly selected clinical trial cohort and reflects a
real-world experience with the Endurant stent graft.
Whereas reinterventions were well captured, the typeand indication of the reinterventions merit further study,
given the higher risk of proximal endoleaks in female
patients. The registry does not capture the indication for
reintervention or what the intervention was. As female
patients had significantly higher rates of type IA endo-
leaks but no difference in reintervention rates, this is an
important limitation. Further study is needed to deter-
mine why female patients have similar reintervention
rates despite higher endoleak rates. As not all interven-
tions are equivalent, a better understanding of the nature
of the interventions in female patients, especially those
with endoleaks, is necessary. In addition, this analysis
does not take into account thosewomenwhose anatomy
precluded them from repair. We also lack long-term data
on sac morphology in patients with endoleaks, so we do
not know how differences in sac behavior may have
contributed to the reintervention rates.
CONCLUSIONS
Despite more challenging anatomy, female patients
treated with the Endurant stent graft demonstrated
comparable perioperative and long-term outcomes to
those of male patients, with similar survival, low rates of
conversion and reintervention, and no aneurysm rup-
tures in follow-up. However, female patients experienced
higher rates of type IA endoleaks, even after accounting
for anatomic differences. Overall, this analysis of the
ENGAGE registry shows that the sex gap has narrowed
with the use of modern low-profile conformable devices
but highlights the potential for further improvement
through the application of EndoAnchor or fenestrated
technologies in patients with adverse neck anatomy.
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